News & Media

Novavax to Host Conference Call to Discuss Third Quarter 2017 Financial Results on November 7, 2017

October 31, 2017

GAITHERSBURG, Md., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter financial and operating results following the close of U.S. financial markets on Tuesday, November 7, 2017.

Conference call details are as follows:

Date:Tuesday, November 7, 2017
Time:4:30 p.m. U.S. Eastern Time (ET)
Dial-in number:(877) 212-6076 (Domestic) or (707) 287-9331 (International)
Passcode:2479419
Webcast:www.novavax.com, “Investors”/ “Events”
 


Conference call and webcast replay:

Dates:Starts at 7:30 p.m. ET, Nov. 7, 2017 until 7:30 p.m. ET, Nov. 14, 2017
Dial-in number:(855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode:2479419
Webcast:www.novavax.com, “Investors”/ “Events”, until February 7, 2018
 

 

About Novavax 

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Its recombinant nanoparticles and Matrix-M™ adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines.

Contact:         

Investor Relations
Novavax, Inc.
Andrea N. Flynn, Ph.D.
Director, Investor & Media Relations
[email protected]
240-268-2000
              
Westwicke Partners
John Woolford
[email protected]
443-213-0506

Media
Russo Partners, LLC
David Schull
Maggie Beller
[email protected]
[email protected]
212-845-4271

The scientific images on this website are generated or enhanced using artificial intelligence. These visuals are for illustrative purposes only. Illustrations of Matrix-M and Protein Nanoparticles are visual representations only.

©2026 Novavax. All rights reserved.